Pharmaceutical Manufacturing Formulations
|
|
|
- Eleanor Dawson
- 9 years ago
- Views:
Transcription
1 HANDBOOK OF Pharmaceutical Manufacturing Formulations Uncompressed Solid Products VOLUME 2 Sarfaraz K. Niazi CRC PRESS Boca Raton London New York Washington, D.C.
2 Table of Contents Parti Regulatory and Manufacturing Guidelines 1 Chapter 1 Global Good Manufacturing Practices Compliance 3 I. Introduction 3 A. General Provisions 5 B. Organization and Personnel 5 C. Buildings and Facilities 6 D. Equipment 7 E. Control of Components and Drug Product Containers and Closures 8 F. Production and Process Controls 9 G. Packaging and Labeling Controls 10 H. Holding and Distribution 13 I. Laboratory Controls 13 J. Records and Reports 15 K. Returned and Salvaged Drug Products 18 Chapter 2 Compliance Program Guidance Manual for FDA Staff: Drug Manufacturing Inspections 21 I. Background 21 II. Implementation 21 A. Objectives 21 B. Strategy Biennial Inspection of Manufacturing Sites Inspection of Systems A Scheme of Systems for the Manufacture of Drugs and Drug Products 22 III. Program Management Instructions 23 A. Definitions Surveillance Inspections Compliance Inspections State of Control Drug Process Drug Manufacturing Inspection 24 B. Inspection Planning 24 C. Profiles 24 IV. Inspectional Observations 25 A. Investigational Operations General Inspection Approaches System Inspection Coverage Sampling Inspection Teams Reporting 29 V. Analytical Observations 30 A. Analyzing Laboratories 30
3 B. Analysis 30 VI. Regulatory /Administrative Strategy 30 Chapter 3 Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate-Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification 33 I. Introduction 33 II. The Biopharmaceutics Classification System 33 A. Solubility 33 B. Permeability 34 C. Dissolution 34 III. Methodology for Classifying a Drug Substance and for Determining the Dissolution Characteristics of a Drug Product 34 A. Determining Drug Substance Solubility Class 34 B. Determining Drug Substance Permeability Class Pharmacokinetic Studies in Humans Intestinal Permeability Methods Instability in the Gastrointestinal Tract 36 C. Determining Drug Product Dissolution Characteristics and Dissolution Profile Similarity 36 IV. Additional Considerations for Requesting a Biowaiver 37 A. Excipients 37 B. Prodrugs 37 C. Exceptions Narrow Therapeutic Range Drugs Products Designed to Be Absorbed in the Oral Cavity 37 V. Regulatory Applications of the BCS 37 A. INDs/NDAs 37 B. ANDAs 38 C. Postapproval Changes 38 VI. Data to Support a Request for Biowaivers 38 A. Data Supporting High Solubility 38 B. Data Supporting High Permeability 38 C. Data Supporting Rapid and Similar Dissolution 39 D. Additional Information 39 References 39 Appendix A 39 Chapter 4 Guidelines on Formulating Uncompressed Solids 41 I. Relative Humidity 41 II. Surface Area 41 III. Sieve Analysis 41 IV. Particle Size Distribution 42 V. Powder Flow Properties 42 VI. Real, Tapped, and Bulk Density 43 VII. Solid Handling 43 VIII. Mixing of Powders 43 IX. Oral Powders 43 X. Capsules 43 XI. FDA Classification of Capsule Types 44 XII. FDA Classification of Powders 45 XIII. Inhalers and Lung Delivery 45 XIV. Problems in Powder Handling 45
4 XV. Capsulation Equipment 46 XVI. Capsule Finishing 46 XVII. Modified-Release Products 46 XVIII. Clinical Test Supplies and Placebos 46 XIX. Coated Particles 46 XX. Mixing Mechanisms 46 XXI. Segregation Mechanisms 46 XXII. Mixing Equipment 47 XXIII. Milling 47 Part II Uncompressed Solids Formulations 49 Acebutolol Hydrochloride Capsules 51 Aceclofenac Instant Granules 51 Acetaminophen and Diphenhydramine Hydrochloride Hot Therapy Sachet 52 Acetaminophen Capsules 500 mg 52 Acetaminophen, Doxylamine, and Caffeine Effervescent 53 Acetaminophen Instant Granules 54 Acetaminophen, Pseudoephedrine Hydrochloride, Chlorpheniramine Hot Therapy Sachet 55 Acetaminophen, Pseudoephedrine Hydrochloride Hot Therapy Sachet 56 Acetaminophen Swallow Capsules 56 Acetazolamide Sustained-Release Capsules 57 Acetylcysteine Sachets 57 Acitretin Capsules 58 Acrivastine and Pseudoephedrine Hydrochloride Capsules 59 Acyclovir Capsules 59 Adenosine Monophosphate Topical Powder 60 Aluminum Acetate Powder 60 Aluminum Hydroxide and Magnesium Carbonate Dry Syrup 60 Aminosalicylic Acid Granules 61 Amlodipine Besylate and Benazepril Hydrochloride Capsules 61 Amlodipine Besylate Capsules 62 Amoxicillin and Bromhexine Hydrochloride Capsules 62 Amoxicillin and Clavulanic Acid Powder for Suspension, 125 mg and mg per 5 ml 63 Amoxicillin and Clavulanate Potassium for Suspension 64 Amoxicillin Powder for Suspension 125 and 250 mg 65 Amoxicillin Trihydrate Capsules 250 and 500 mg 65 Ampicillin Powder for Suspension 66 Ampicillin Trihydrate Capsules 66 Ampicillin Trihydrate Capsules for Suspension 67 Ampicillin Trihydrate Powder for Suspension 67 Antibacterial and Bacterial Culture Capsules 68 Antifungal Foot Powder 68 Aspartame Granules in Sachet 69 Aspartame Powder in Sachet 69 Aspirin and Chlorpheniramine Powder 69 Aspirin and Phenylpropanolamine Powder 70 Aspirin Microencapsulated Sustained-Release Capsules 70 Aspirin, Salicylamide, and Caffeine Powder 70 Azithromycin Capsules 71 Azithromycin Capsules and Oral Suspension 72 Azithromycin for Oral Suspension "72
5 Azithromycin Sachet for Oral Suspension 73 Balsalazide Disodium Capsules 74 Benazepril Hydrochloride and Amlodipine Besylate Capsules 75 Bisacodyl Colonic Delivery Capsules 76 Brompheniramine and Pseudoephedrine Capsules 76 Budesonide Capsules 77 Budesonide Inhalation Powder 77 Butalbital and Acetaminophen Capsules 77 Calcitonin (Salmon) Capsules 78 Calcitriol Capsules 79 Calcium Carbonate Microencapsulated Sustained-Release Capsules 80 Camptothecin Capsules 80 Carbamazepine Extended-Release Capsules 81 Cefaclor Capsules 82 Cefdinir Capsules and Oral Suspension 82 Cefixime for Oral Suspension 82 Cefpodoxime Proxetil for Oral Suspension 82 Cefprozil for Oral Suspension 83 Ceftibuten Capsules and Oral Suspension 83 Ceftibutin for Oral Suspension 83 Cefuroxime for Oral Suspension 84 Celecoxib Capsules 84 Cellulose Triacetate Liquefiable Topical Powder 85 Cephalexin Capsules 85 Cephalexin Powder for Oral Suspension 86 Cephradine Capsules 86 Cephradine Powder for Suspension 87 Cevimeline Capsules 87 Chlordiazepoxide Hydrochloride Capsules 88 Chloroxylenol and Chlorhexidine Topical Powder 88 Chlorpromazine Sustained-Release Capsules 89 Cimetidine Microencapsulated Sustained-Release Capsules 89 Citrate Effervescent Powder 90 Clindamycin Capsules 150 mg 90 Clofibrate Capsules 91 Clonidine Sustained-Release Capsules 91 Clorazepate Dipotassium Capsules 92 Cyclosporin A Capsules 92 Dantrolene Sodium Capsules 93 Dextroamphetamine Sulfate Capsules 93 Diclofenac and Misoprostol Capsules 93 Diclofenac Sustained-Release Capsules 94 Didanosine Delayed-Release Capsules 95 Didanosine Delayed-Release Capsules Enteric-Coated Beadlets 95 Didanosine for Oral Suspension 95 Diethyl Toluamide Topical Powder 96 Difluoromethylornithine-Alpha Capsules 97 Diltiazem Hydrochloride Extended-Release Capsules 99 Diphenhydramine Hydrochloride Capsules 100 Dipyridamole and Aspirin Extended-Release Capsules 100 Divalproex Sodium Capsules 100 Divalproex Sodium Coated Particle Capsules 100 Dofetilide Capsules 100 Doxepin Hydrochloride Capsules 101 Doxycycline Capsules 101 Doxycycline Hyclate Capsules 101
6 Doxycycline Hydrochloride Capsules and Oral Suspension 102 Efavirenz Capsules 102 Enalapril Maleate Capsules 102 Erythromycin and Bromhexine Powder for Suspension 103 Erythromycin and Sulfisoxazole Granules for Suspension 104 Erythromycin Delayed-Release Capsules 105 Erythromycin Ethylsuccinate for Oral Suspension 106 Erythromycin Ethylsuccinate for Oral Suspension 200 mg/5 ml 107 Erythromycin Stearate for Oral Suspension 108 Erythropoietin Capsules 110 Esomeprazole Magnesium Capsules Ill Estramustine Phosphate Capsules Ill Ethosuximide Capsules 112 Etodolac Capsules 112 Eye Nutrition Supplement Capsules 112 Felbamate for Oral Suspension 112 Fenofibrate Capsules 113 Fexofenadine Hydrochloride Capsules 114 Fluconazole for Oral Suspension 114 Flucytosine Capsules 114 Fluoxetine Capsules 115 Fluoxetine Hydrochloride Capsules 115 Fluoxetine Hydrochloride Instant and Weekly Capsules 116 Flutamide Capsules 116 Fluticasone Propionate and Salmeterol Xinafolate Inhalation Powder 116 Fluvastatin Sodium Capsules 117 Formoterol Fumarate Inhalation Powder 117 Formoterol Fumarate Inhaler Capsules 117 Fosfomycin Tromethamine Sachets 118 Gabapentin Capsules 118 Ganciclovir Capsules 118 Gemfibrozil Capsules 119 Glycoprotein Ila/IIb Capsules 119 Guaifenesin Sustained-Release Capsules 120 Herbal AIDS Treatment Capsules 120 Histadine Capsules 120 Human Growth Hormone Capsules 121 Hydrochlorothiazide and Triamterene Capsules 122 Hydrochlorothiazide Capsules 122 Hydroxyzine Pamoate Capsules and Oral Suspension 122 Hyoscyamine Sulfate Capsules 122 Ibuprofen Microencapsulated Sustained-Release Capsules 123 Ibuprofen Sustained-Release Capsules 124 Ifosfamide Capsules 125 Imatinib Mesylate Capsules 125 Indinavir Sulfate Capsules 126 Indomethacin Capsules 127 Indomethacin Microencapsulated Sustained-Release Capsules 129 Indomethacin Sustained-Release Capsules 130 Insulin Capsules '31 Iron-Polysaccharide Complex Capsules 132 Isometheptene Mucate, Dichloralphenazone, and Acetaminophen Capsules '32 Isosorbide Mononitrate Capsules 20 mg 133 Isradipine Capsules '33 Itraconazole Capsules '34 Ketoprofen and Misoprostol Capsules 134
7 Ketoprofen Capsules 135 Lansoprazole Capsules 135 Lansoprazole Delayed-Release Capsules 135 Lincomycin Capsules 136 Linezolid Oral Suspension 136 Lipase, Amylase, and Protease Capsules 136 Lithium Carbonate Capsules 136 Lopinavir-Ritonavir Capsules 137 Loracarbef Capsules and Oral Suspension 137 Loxapine Capsules 137 Loxapine Succinate Capsules 137 Magaldrate Instant Powder or Dry Syrup 138 Magnesium Oxide Capsules 138 Mefenamic Acid Capsules 138 Mesalamine Capsules 138 Mesalamine Colonic Delivery Capsules 139 Methsuximide Capsules 139 Methylphenidate Capsules 140 Methylphenidate Immediate- and Extended-Release Capsules 140 Methyltestosterone Capsules 141 Metoclopramide Hydrochloride Sustained-Release Capsules 141 Metyrosine Capsules 142 Miconazole Nitrate Foot and Itch Powder 142 Mineral Powder for Topical Herpes Simplex 142 Minocycline Hydrochloride Capsules 142 Mixed Amphetamine Salt Capsules 143 Mixed Amphetamine Salts Enteric-Release Capsules 143 Morphine Sulfate Capsules 144 Morphine Sulfate Controlled-Release Capsules 145 Morphine Sulfate Sustained-Release Capsules 146 Multivitamin Effervescent Granules 147 Multivitamin Instant Granules 148 Mycophenolate Mofetil Capsules and Oral Suspension 148 Nanoparticle Polymer Particle Powders 149 Nelfinavir Mesylate Oral Powder 150 Nilvadipine Capsules 150 Nitrofurantoin Capsules 150 Nitrofurantoin Sustained-Release Capsules 151 Nizatidine Capsules 151 Nystatin Powder 151 Omeprazole and Piroxicam Capsules 152 Omeprazole Capsules 153 Omeprazole Delayed-Release Capsules 153 Oral Rehydration Salt 45 meq 154 Orlistat Capsules 155 Oseltamivir Phosphate Capsules and Oral Suspension 156 Oxcarbazepine Oral Suspension 156 Oxycodone Hydrochloride and Acetaminophen Capsules 156 Oxytetracycline Hydrochloride Capsules 157 Oxytetracycline Hydrochloride, Sulfamethizole, and Phenazopyridine Hydrochloride Capsules 157 Pancrealipase Capsules 157 Pancrealipase Capsules Enteric-Coated Microspheres 158 Penicillamine Capsules 158 Pentosan Polysulfate Sodium Capsules 158 Pentostatin Capsules 158 Phenobarbital and Hyoscyamine Sulfate Capsules 158
8 Phenoxybenzamine Hydrochloride Capsules 159 Phentermine Capsules 159 Phentermine Hydrochloride Capsules 159 Phenytoin Sodium Extended-Release Capsules 159 Piroxicam and Beta-cyclodextrin Topical Powder 160 Piroxicam Capsules 161 Polyethylene Glycol 3350 Powder for Reconstitution 162 Polythiazide Capsules 162 Potassium Chloride Extended-Release Capsules 162 Potassium Chloride for Oral Solution 162 Potassium Chloride Microencapsulated Sustained-Release Capsules 163 Potassium Chloride Powder 20 meq 164 Prazosin and Polythiazide Capsules 164 Prednisolone Targeted-Release Capsules 165 Procarbazine Hydrochloride Capsules 165 Prochlorperazine Sustained-Release Capsules 165 Propoxyphene Hydrochloride, Caffeine, and Aspirin Capsules 166 Propoxyphene Hydrochloride Capsules 166 Propranolol Hydrochloride and Hydrochlorothiazide Capsules 166 Propranolol Hydrochloride Long-Acting Capsules 166 Propranolol Hydrochloride Multiple Bead Capsules 167 Propranolol Hydrochloride Sustained-Release Capsules 169 Propranolol Timed- and Sustained-Release Capsules 170 Pseudoephedrine and Guaifenesin Capsules 170 Pseudoephedrine Hydrochloride Capsules 170 Ranitidine Effervescent Granules 171 Ribavirin Capsules 171 Rifabutin Capsules 171 Rifampicin Capsules 171 Rifampin and Isoniazid Capsules 171 Rivastigmine Tartrate Capsules 172 Salmeterol Xinafolate Capsules 172 Salmeterol Xinafolate Inhalation Powder 172 Saquinavir Mesylate Capsules 172 Selegiline Hydrochloride 173 Sevelamer Hydrochloride Capsules 173 Sibutramine Hydrochloride Capsules 173 Stavudine Capsules '73 Succimer Capsules 174 Sucralafate Granules '74 Tacrine Hydrochloride Capsules 174 Tacrolimus Capsules '75 Talc, Crospovidone, and Starch Topical Powder 175 Tamsulosin Hydrochloride Capsules 176 Temazepam Capsules '77 Temozolomide Capsules '77 Terazosin Hydrochloride Capsules 178 Tetracycline Hydrochloride Capsules '78 Thalidomide Capsules 17^ Theophylline Sustained-Release Capsules 179 Thiothixene Capsules '7 l) Tibolone Capsules 1X() Tiotropium Inhalation Powder l^(l Tolmetin Sodium Capsules lx ' Tolterodine Capsules IX ' Topiramate Capsules ' xl
9 Tretinoin Capsules 182 Triamterene and Hydrochlorothiazide Capsules 182 Triamterene Capsules 182 Triclosan and Zinc Undecylenate Powder 183 Trientine Hydrochloride Capsules 183 Trimethoprim and Sulfamethoxazole Oral Suspension 183 Trimipramine Maleate Capsules 183 Troleandomycin Capsules 184 Typhoid Vaccine Live Oral Capsules 184 Valsartan and Hydrochlorothiazide Capsules 184 Valsartan Capsules 185 Vancomycin Hydrochloride Capsules 185 Verapamil Hydrochloride Capsules 186 Verapamil Hydrochloride Sustained-Release Capsules 187 Vincamine Capsules 188 Vinpocetine Multiple Bead Capsules 189 Vitamin B-Complex, Amino Acids, and Magnesium Effervescent Granules (Sugar-Free) 190 Vitamin B-Complex and Vitamin C Instant Granules 191 Vitamin C and Calcium Carbonate Effervescent Tablets 191 Zanamivir Powder 192 Zidovudine Capsules 192 Zinc Oxide and Cornstarch Powder 192 Ziprasidone Hydrochloride Capsules 193 Zonisamide Capsules 194 Index 195
PREFERRED GENERIC DRUG LIST
These discount programs are NOT health insurance policies and are not intended as a substitute for insurance. The programs do not qualify as a minimum creditable coverage under Massachusetts law or where
PROJECT LIST GENERIC PRODUCTS
PROJECT LIST GENERIC PRODUCTS Acetylcysteine, Effervescent tablets 200 mg, 600 mg Alendronate sodium, Tablets 10, 70 mg Alfuzosin,Tablets 2.5mg Alfuzosin, ER Tablets 10 mg Ambroxol, Effervescent tablets
$10.00 PRESCRIPTION PROGRAM DETAILS
$10.00 PRESCRIPTION PROGRAM DETAILS 1. The $10.00 program applies only to certain generic drugs at commonly prescribed 90 day usage dosages. (See list). 2. The Program may change without notification and
Drugs to consider prescribing by brand name or where brands should not be switched
Index Page Index Page Adrenaline (epinephrine) prefilled syringes 2 Hormone replacement therapy oral 3 Alprostadil injection 4 Human papillomavirus vaccine 5 Aminophylline modified release 2 Insulins 3
Guidance for Industry
Guidance for Industry Immediate Release Solid Oral Dosage Forms Scale-Up and Postapproval Changes: Chemistry, Manufacturing, and Controls, In Vitro Dissolution Testing, and In Vivo Bioequivalence Documentation
for Extended Stability Parenteral Drugs Third Edition Caryn M. Bing, R.Ph., M.S., FASHP Editor
Extended Stability for Parenteral Drugs Third Edition Editor Caryn M. Bing, R.Ph., M.S., FASHP 1 American Society of Health-System Pharmacists Bethesda, Maryland Contents Preface Acknowledgments x/ Dedication
Directory of Generic Medications Eligible for Rx Savings Program Flat Fees
Directory of Generic Medications Eligible for Rx Savings Program Flat Fees CONNECTICUT VERSION If you re already enrolled in the FREE* Rx Savings Program, use this guide to find your best choices. And,
The 365-day period begins with the first dispensing transaction for each Ontario Drug Benefit (ODB) recipient on or after October 1, 2015.
Ontario Public Drug Programs, Ministry of Health and Long-Term Care Chronic-use Medications List by In accordance with subsection 18 (11.1) of Ontario Regulation 201/96 made under the Ontario Drug Benefit
. ก ก 1. Actifed tab/syr. Triprolidine : should be stored in tight, light-resistant Pseudoepedrine : Triprolidine (p.25) Pseudoepedrine (p.
ก ก. 2553 (p.807) 3. Adrenaline inj. 1mg/ml (Epinephrine inj.) ( Druginfor. p.629) 4. Aminophylline/ Theophylline inj. (Drug infor. Ed. 11 th p.1339) 5. Amlodipine + HCTZ (Moduretic). ก ก 1. Actifed tab/syr.
Generic Pharmacy Discount
Generic Pharmacy Discount 83 Park Place Blvd Suite 101 Clearwater, FL 33759 Fourth Quarter 2014 727.461.6044 800.314.0088 Pharmacies Generic Discount Program Information Enclosed information provided
Ship to: Payment: Item# Lot# 1.60 1.2 % Menthol 2.6 %; topical ointment Acetaminophen Susp.160mg/5mL, Bott/100mL 0000000100 3BK0215
97 060-B Lorimar Drive Mississauga ON LS R8 PHONE:(90) 670-990 FAX:(90) 670-78 ShipDate: 0// Shipper# PTP97- Chest Rub Ointment, Jar/00g 000000008 0/0/ VI-JON INC JAR/00G,7,7-Trimethylbicyclo[..]heptan--one.8
$4, 30-day $10, 90-day
$4 Prescriptions - Choose from hundreds of generic drugs and over the counter medications. Free Home Delivery Mailed right to your home Free shipping Prescription Program includes up to a 30-day supply
Date: November 30, 2010
Department of Health and Human Services Public Health Service Food and Drug Administration Center for Drug Evaluation and Research Date: November 30, 2010 To: Through: From: Subject: Drug Name(s): Application
Pharmacy Savings Program
Pharmacy Savings Program SELECT GENERICS DRUG LIST The Pharmacy Savings Program provides you with savings on select generic medications included on this list. The prices for these select generic medications
Palliative Care Drug Plan (Plan P) Formulary List of drugs PharmaCare covers
Palliative Care Drug Plan (Plan P) Formulary List of drugs PharmaCare covers Important Notes: Last Updated: May 11, 2015 Pharmacists must submit a claim on PharmaNet at the time of purchase to enable coverage.
Retail Prescription Program Drug List
Retail Prescription Program Drug List Price Matters New Men s Health Category Convenience Free Home Delivery Our 4 prescriptions have saved our customers over 3 billion The program is available to everyone,
Drug Use Review. Edward Cox, M.D. Director Office of Antimicrobial Products
Department of Health and Human Services Public Health Service Food and Drug Administration Center for Drug Evaluation and Research Drug Use Review Date: April 5, 2012 To: Through: Edward Cox, M.D. Director
Anti Protozoal. Albendazole Oral Suspension USP Albendazole Tablets USP 400 mg Anti Malarial
ANTI-INFECTIVES Anti Biotics Levofloxacin Tablets 250, 500, 750 mg Ofloxacin Tablets 200, 400 mg Sparfloxacin Tablets 200 mg Ciprofloxacin Tablets USP 250, 500 mg Ofloxacin & Ornidazole Tablets Nitrofurantoin
It's in the details. JOST MINERAL GUIDE
It's in the details. JOST MINERAL GUIDE Reference Guide to Jost Mineral Compounds Jost Chemical Co. manufactures a line of mineral compounds that are used in the nutritional supplement, clinical nutrition,
MICHILD CHILDREN S SPECIAL HEALTH CARE SERVICES (CSHCS) FORMULARY Effective October 2015
MICHILD CHILDREN S SPECIAL HEALTH CARE SERVICES (CSHCS) FORMULARY Effective October 2015 Provided by EnvisionRxOptions Introduction The Total Health Care (THC) MIChild Children s Special Health Care Services
Each un coated tablet contains: Nimesulide. Each un coated tablet contains: Nimesulide Paracetamol
Sr No. Generic Name Composition Claim 1 Tabs. 100/ 2 + Para Tabs. 3 + Tizanidine Tabs. 4 + Tabs. 5 +Serratio Tabs. 6 +Serratio Tabs. 7 Aceclo Tabs. IP 8 Aceclo + Para Tabs. 9 Aceclo + Para + Chlorzoxazone
NEW SCHEDULE H1 INSERTED IN DRUGS AND COSMETICS RULES :
LOCOST 85, GIDC Estate, Por-Ramangamdi, N.H.8, Dist. Vadodara - 391 243 Gujarat, India. Tel. No.: (91-265) 2830009 Fax No.: (P.P.) 2831446 E-mail: [email protected] Website: www.locostindia.com A Public
How To Get A Drug Plan To Pay For A Prescription From Acpa
+B/LVW2I'UXJV5B$SSURYHG 2015 List of Covered s (Formulary) FOR MORE INFORMATION, contact Member Services at 1-855-735-4398 from 8 a.m. to 8 p.m., seven days a week. TTY users call 711. On weekends and
DRAFT GUIDANCE. This guidance document is being distributed for comment purposes only.
Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate-Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification System Guidance for Industry DRAFT GUIDANCE This guidance
Bioequivalence Study Design Considerations. Dr. John Gordon
Bioequivalence Study Design Considerations Dr. John Gordon Key Output of Programme A list of prequalified medicinal products used for treatment of HIV/AIDS, malaria, tuberculosis, influenza, and for reproductive
612 Program Midtown Express Pharmacy
ALENDRONATE SOD TAB 35MG (max 1 per week) $37.00 $70.00 ALENDRONATE SOD TAB 70MG (max 1 per week) $37.00 $70.00 ALLOPURINOL TAB 100MG $20.00 $38.00 ALLOPURINOL TAB 300MG $20.00 $38.00 AMITRIPTYLINE TAB
Product Catalog. 65862-0073-60 Abacavir Tablets 300 mg 60 80 80 AB Ziagen Yellow
65862-0073-60 Abacavir Tablets 300 mg 60 80 80 AB Ziagen Yellow 13107-0058-01 Acetaminophen & Codeine Tablets, C-III 300 mg / 15 mg 100 216 216 AA Tylenol-Codeine White/Off-White 13107-0059-01 Acetaminophen
Measuring Generic Efficiency in Part D
Measuring in Part D Rates among Medicare Part D Generic efficiency rate is a measurement of the total number of prescrip=ons filled as a generic for products with a direct generic subs=tute within a therapeu=c
2015 Formulary (List of Covered Drugs)
Blue Cross Medicare Advantage Basic (HMO) SM Blue Cross Medicare Advantage Premier Plus (HMO-POS) SM 015 Formulary (List of Covered Drugs) PLEASE READ: THIS DOCUMENT CONTAINS INFORMATION ABOUT THE DRUGS
FORMULARY. (List of Covered Drugs) Molina Dual Options Medicare-Medicaid Plan
FORMULARY (List of Covered Drugs) 2015 Molina Dual Options Medicare-Medicaid Plan Version 14 UPDATED: 11/2015 Member Services (877) 901-8181, TTY/TDD 711 Monday - Friday, 8 a.m. - 8 p.m. local time H8046_15_16003_0002_MMPILRx
BIOTECHNOLOGY SYNTHESIS CORTICOSTEROIDS FRANCOPIA PROSTAGLANDINS PRODUCT LIST JUNE 2013
BIOTECHNOLOGY SYNTHESIS CORTICOSTEROIDS FRANCOPIA PROSTAGLANDINS PRODUCT LIST JUNE 2013 Validity of this document: December 2013 API Name Business Unit Page API Name Business Unit Page Acebutolol hydrochloride
Members enjoy more Pharmacy savings *
Sam s Plus Members enjoy more Pharmacy savings 5 prescription drugs available for FREE Generic medications: Donepezil, Pioglitazone, Escitalopram, Finasteride and Vitamin D2 50,000IU are $ 0 for a 30-day
Guidance for Industry
Guidance for Industry Food-Effect Bioavailability and Fed Bioequivalence Studies U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER)
SCHEDULE No. 1: Oral solid dosage forms: Fluoroquinolones
ANNEX B/ SECTION 8: TECHNICAL SPECIFICATIONS NOTE: The estimated Global need for required below products is provided in Annex H of this ITB. Actual quantity to be ordered in 2015 can vary due to countries
(Comprehensive list of covered drugs)
Standard Plan 015 Prescription Drug Formulary (Comprehensive list of covered drugs) +306$SSURYHG)RUPXODU\)LOH6XEPLVVLRQ,'9HUVLRQ1XPEHU16 This document contains information about the drugs we cover in this
Overview of Dissolution for BA/BE
Biopharmaceutics Classification System based on Solubility/Permeability Biowaivers for BCS I Drugs Discussion of BCS III Drugs Models establishing in vivo-in vitro Correlations (IVIVC Levels A-C) 1 Biopharmaceutics
Home Delivery Prescription Program Drug List
Home Delivery Prescription Program Drug List Low-cost prescriptions, right in your mailbox. Now you can have your generic prescriptions mailed right to your home, no matter where you live. Because we think
BC Cancer Agency & Canadian Cancer Society Financial Support Drug Program (FSDP) for Cancer Patients. Drug Benefit List. Updated February 15, 2016
BC Cancer Agency & Canadian Cancer Society Financial Support Drug Program (FSDP) for Cancer Patients Drug Benefit List Updated February 15, 2016 The FSDP will operate following rules established by the
Bundesinstitut für Arzneimittel und Medizinprodukte. Dissolution Testing. Analytik,Methodenentwicklung, Bioäquivalenz SAQ. Olten, 25.
Dissolution Testing Analytik,Methodenentwicklung, Bioäquivalenz SAQ Olten, 25. Januar 2006 Dr. H. Potthast ([email protected]) 1 2 Basis for Biowaiver Applications/Decisions Note for Guidance on the
Pharmaceutical Manufacturing Formulations Over-the-Counter Products VOLUME 5
HANDBOOK OF Pharmaceutical Manufacturing Formulations Over-the-Counter Products VOLUME 5 Sarfaraz K. Niazi CRC PRESS R. n o n I n M i l i i i i N V \ \ V > i k \\.i-.li nn;i< H I. I Vl Table of Contents
GDUFA Regulatory Science Update
GDUFA Regulatory Science Update Robert Lionberger, Ph.D. Director Office of Research and Standards Office of Generic Drugs Center for Drug Evaluation and Research, FDA GPhA Annual Meeting Feb 9, 2015 Goals
AETNA BETTER HEALTH OF OHIO a MyCare Ohio plan
AETNA BETTER HEALTH OF OHIO a MyCare Ohio plan 2015 List of Covered Drugs/Formulary Aetna Better Health of Ohio, a MyCare Ohio plan (Medicare-Medicaid Plan) is a health plan that contracts with Medicare
Generic drugs are copies of innovator drug products
dx.doi.org/10.14227/dt190412p51 In Vitro Equivalence Studies of Generic Metformin Hydrochloride Tablets and Propranolol Hydrochloride Tablets Under Biowaiver Conditions in Lagos State, Nigeria e-mail:
QbD Understanding How Excipient Properties Influence Solid Oral Dosage Form Performance
QbD Understanding How Excipient Properties Influence Solid Oral Dosage Form Performance Dr Amina Faham (Dow), Dr Liz Meehan (AstraZeneca) ExcipientFest, Amsterdam NL June 24, 2014 What do you understand
Dosing information in renal impairment
No. Drug name Usual dose Adjustment for Renal failure estimated CrCl (ml/min) Aminoglycoside antibiotics 1 Amikacin 2 Gentamicin 7.5 mg /kg q 12 hr > 50-90 7.5 mg/kg q 12 hr 10-50 7.5 mg/kg q 24 hr < 10
Emit Drugs of Abuse Urine Assays Cross-Reactivity List. Answers for life.
Emit Drugs of Abuse Urine Assays Cross-Reactivity List Answers for life. Contents Emit II Plus Amphetamines...4 Emit II Plus Barbiturate...8 Emit II Plus Benzodiazepine... 12 Emit II Plus Cannabinoid...
Guidance for Industry
Guidance for Industry Bioavailability and Bioequivalence Studies for Orally Administered Drug Products General Considerations U.S. Department of Health and Human Services Food and Drug Administration Center
Preferred Drug List. (List of Covered Drugs) This document includes Passport Health Plan s complete 2015 formulary.
Drug List (List of Covered Drugs) This document includes Passport Health Plan s complete 2015 formulary. What is the Passport Health Plan formulary? The formulary is a list of preferred drugs covered by
Appendix 4: Guidelines for Prescribing and Administering Drugs:
Appendix 4: Guidelines for Prescribing and Administering Drugs: A midwife may prescribe and administer the following substances in accordance with the guidelines approved by the Board. This list indicates
PREFERRED GENERIC DRUG LIST
ALLERGIES & COLD AND FLU Preferred generic drugs MARCH 2013 supply* for $5 supply* for $10 and $15 * The day supply is based upon the average dispensing patterns for the specific drug and strength. 90-
Magellan Rx Medicare Basic (PDP) 2016 Formulary. (List of Covered Drugs)
Magellan Rx Medicare Basic (PDP) 2016 Formulary (List of Covered Drugs) PLEASE READ: THIS DOCUMENT CONTAINS INFORMATION ABOUT THE S WE COVER IN THIS PLAN Formulary File 16144, Version 22 This formulary
Prescription drug products stability and expiration dates*
Prescription drug products stability and expiration dates* UTMB/NASA-JSC Aerospace Medicine Grand Rounds Houston, TX October 27, 2009 Mansoor A. Khan, R.Ph., Ph.D. Director, FDA/CDER/Division of Product
Public Assessment Report. Scientific discussion. Calcium and Vitamine D3 Alpex 1000 mg/880 IE, effervescent granules
Public Assessment Report Scientific discussion Calcium and Vitamine D3 Alpex 1000 mg/880 IE, effervescent granules (calcium carbonate and cholecalciferol) NL License RVG: 111783 Date: 12 March 2015 This
UnitedHealthcare Group Medicare Advantage (PPO)
Your Plan Explained UnitedHealthcare Group Medicare Advantage (PPO) UHEX11MP3230855_001 Y0066_100616_09113 Your Medicare. This brochure explains your Medicare Advantage plan, a type of health plan also
Product list Magnesium, Calcium and further mineral compounds
Product list Magnesium, Calcium and further mineral compounds Product list Magnesium, Calcium and further mineral compounds A Aluminium stearate Aluminium sulphate C Calcium acetate Calcium ascorbate L-Calcium
Bulletin #29. Manitoba Drug Benefits and Interchangeability Formulary Amendments
Manitoba Drug Benefits and Interchangeability Formulary Amendments The following changes will be made to the Pharmacare benefit list effective March 1, 2001 Inside This Issue Part 1 Additions pg. 2 Part
Appropriate Treatment for Children with Upper Respiratory Infection
BCBS ACO Measure Appropriate Treatment for Children with Upper Respiratory Infection HEDIS Measure CPT II coding required: YES Click here to go to Table of Contents BCBS Measure: Page 50 of 234 Dated:
Summary Public Assessment Report. Generics
Summary Public Assessment Report Generics 875 mg + 125 mg, Film-coated tablets (Amoxicillin Trihydrate + Potassium Clavulanate) Date: 29-12-2014 1/7 Summary Public Assessment Report Generics Amoxicillin
Summary Public Assessment Report. Generics. Amoxicilina + Ácido Clavulânico Ranbaxy,
Summary Public Assessment Report Generics Amoxicilina + Ácido Clavulânico Ranbaxy 875 mg + 125 mg, Film-coated tablets (Amoxicillin Trihydrate + Potassium Clavulanate) Date: 29-12-2014 1/7 Summary Public
2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY
Measure #65 (NQF 0069): Appropriate Treatment for Children with Upper Respiratory Infection (URI) National Quality Strategy Domain: Efficiency and Cost Reduction 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES:
Pharmaceutical Issues when Crushing, Opening or Splitting Oral Dosage Forms June 2011
Pharmaceutical Issues when Crushing, Opening or Splitting Oral Dosage Forms June 2011 Introduction It is important to recognise the potential consequences of manipulating a medicinal product. Changing
Scott & White Health Plan Formulary
Scott & White Health Plan Formulary 3 rd Qtr 2015 P a g e 2 Table of Contents What is my prescription drug coverage?... 3 What is the Scott & White Health Plan formulary?... 3 How was the formulary created
How To Understand The Pharmacology Of The Pharmaceutical Industry
It; MM MODERN Ul NDUSTRY 77 /
Public Assessment Report Scientific discussion. Prednisolon Alternova (previous Prednisolon E Consult) (prednisolone) Asp no: 2011-0921
Public Assessment Report Scientific discussion Prednisolon Alternova (previous Prednisolon E Consult) (prednisolone) Asp no: 2011-0921 This module reflects the scientific discussion for the approval of
AETNA BETTER HEALTH Over the counter (OTC) product list
TOPICAL ANTIBACTERIAL/ANTIFUNAL OTC DRUGS OTC bacitracin topical ointment OTC clotrimazole (vaginal use) OTC clotrimazole (topical use) OTC miconazole 2% ointment OTC miconazole vaginal suppositories,
The Grand Master vs. New Kids on the Block
Hong Kong Pharmacy Conference 2013: Therapeutic Debate - Session 1 The Grand Master vs. New Kids on the Block Should warfarin or new oral anticoagulants (NOACs) claim the throne as 1st line agent for stroke
An Overview of Mayo Clinic Tests Designed for Detecting Drug Abuse
Drug Testing An Overview of Mayo Clinic Tests Designed for Detecting Drug Abuse Printed on August 18, 2016 1:59 pm CST 2016 Mayo Foundation for Medical Education and Research (MFMER). All rights reserved.
Introduction... The MeridianRx Pharmacy and Therapeutics Committee (P&T)... Notice... Preface... Product Selection Criteria...
2015 Introduction... 5 The MeridianRx Pharmacy and Therapeutics Committee (P&T)... 5 Notice... 5 Preface... 5 Product Selection Criteria... 5 Formulary Components... 5 Generic Substitution... 5 Covered
FORMULATION EVALUATION AND OPTIMIZATION OF AN ORAL IMMEDIATE RELEASE ANTIBIOTIC FORMULATION OF AMOXICILLINE
e-issn 2249 7706 print-issn 2249 7714 International Journal of Advanced Pharmaceutics www.ijapjournal.com FORMULATION EVALUATION AND OPTIMIZATION OF AN ORAL IMMEDIATE RELEASE ANTIBIOTIC FORMULATION OF
1 Manipulation of formulae and dilutions
1 Manipulation of formulae and dilutions This first chapter of questions is specifically designed to cover a range of numeracy skills. It will give the user further experience in the skills of addition,
Guidance for Industry
Guidance for Industry Bioavailability and Bioequivalence Studies Submitted in NDAs or INDs General Considerations DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments
Table 1. Pure superdisintegrant tablet formulation. Material % w/w Weight (mg) Superdisintegrant 99 277.2 Stearic acid 1 2.
PHARMACEUTICAL TECHNOLOGY REPORT Ashland Specialty Ingredients ashland.com PTR-95 Page 1 of 5 Utility of Polyplasdone as a Tablet Binder Quyen Schwing, Marvin Davis, Divya Tewari, Thomas Dürig Ashland
Generic Drug Formulations. with. and. Kollidon SR
Generic Drug Formulations with Kollicoat SR 3 D and Kollidon SR Contents I. Kollicoat SR 3 D Coating 1.1 Theophylline sustained-release pellets 1.2 Theophylline sustained-release pellets (drug-layering
Public Assessment Report. UK National Procedure. (colecalciferol) PL 16508/0047 PL 16508/0048. ProStrakan Ltd.
Public Assessment Report UK National Procedure STEXEROL-D 3 1,000 IU FILM-COATED TABLETS STEXEROL-D 3 25,000 IU FILM-COATED TABLETS (colecalciferol) PL 16508/0047 PL 16508/0048 ProStrakan Ltd. 1 LAY SUMMARY
Extra Value Drug List. *
List. * Brand Diabetes Levemir 100 units/ml Vial 10mL $122.29 Levemir FlexPen 100 units/ml 15mL $203.03 NovoLog 100 units/ml Vial 10mL $116.84 NovoLog FlexPen Syringe 15mL $222.41 NovoLog 100 units/ml
MEDICATION GUIDE CellCept [SEL-sept] (mycophenolate mofetil capsules) (mycophenolate mofetil tablets)
MEDICATION GUIDE CellCept [SEL-sept] (mycophenolate mofetil capsules) (mycophenolate mofetil tablets) CellCept Oral Suspension (mycophenolate mofetil for oral suspension) CellCept Intravenous (mycophenolate
The Novel Oral Anticoagulants
Induction and Follow up: The Novel Oral Anticoagulants Frances Akinwunmi, Consultant Pharmacist, Anticoagulation Imperial College Healthcare NHS Trust Overview Recap on context NICE guidance Key features
BlueSaver Generic Preventive Care Drug Program List
An independent licensee of the Blue Cross and Blue Shield Association. BlueSaver Generic Preventive Care Drug Program List Preventive care drugs are drugs that can help keep you from developing a health
Use of High Risk Medications in the Elderly (DAE)
Use of High Risk Medications in the Elderly (DAE) Contents OVERVIEW... 1 TECHNICAL SPECIFICATIONS... 3 APPENDIX 1... 5 OVERVIEW Measure Description The percentage of patients 65 years of age and older
AvMed Medicare Choice
AvMed Medicare Choice 2016 Comprehensive Formulary (List of Covered Drugs) PLEASE READ: THIS DOCUMENT CONTAINS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN Note to existing members: This formulary
PREPARATION AND EVALUATION OF STARCH PHOSPHATE- A NEW MODIFIED STARCH AS A DISINTEGRANT IN TABLET FORMULATIONS
Int. J. Chem. Sci.: 9(2), 2011, 889-899 Int. J. Chem. Sci.: ISSN 9(1), 0972-768X 2011, 1-11 www.sadgurupublications.com PREPARATIN AND EVALUATIN F STARCH PHSPHATE- A NEW MDIFIED STARCH AS A DISINTEGRANT
THE PHARMACEUTICAL INDUSTRY
TE PARMACEUTICAL INDUSTRY The pharmaceutical industry in New Zealand takes the active ingredients of drugs (which are imported from overseas) and converts them into a form that can easily be given to a
Introduction to Enteris BioPharma
Introduction to Enteris BioPharma Enteris BioPharma Intelligent Solutions for Oral Drug Delivery Privately held, New Jersey based biotech company Owned solely by Victory Park Capital, a large Chicago based
PHARMACOLOGICAL PROPERTIES
ANTİ-FOSFAT ca 700 mg Film Tablet COMPOSITION 1 film tablet contains 700 mg Calcium acetate, as an active ingredient. Excipients are Microcrystalline cellulose, Povidone K30, Crosspovidone, Magnesium stearate,
Table 121-0030-1 Oregon Fee-for-Service Enforceable Physical Health Perferred Drug List Effective May 1, 2014
System Allergy/Cold Class Preferred Antihistamines - 2nd Generation CETIRIZINE HCL CETIRIZINE HCL LORATADINE LORATADINE TAB RAPDIS *** LORATADINE Analgesics Gout ALLOPURINOL COLCHICINE/PROBENECID Analgesics
Order No. Date Surgery DRUG ORDER SHEET. Page 1. Quantity Unit Total Ordered Cost Cost. Order No. Date
Order No. Surgery Page 1 Aciclovir 800mg (35) Tabs Aciclovir 400mg (56) Tabs Adrenaline 1:10000 Aerospacer adult Aerospacer child/baby with mask Amitriptiline 10mg Amoxicillin 125/5 syrup 100 mls Amoxicillin
Urine drug screens. Screening Methods
Screening Methods Urine drug screens Urine drug screens are generally performed using either immunoassays or gas chromatography-mass spectrometry (GC-MS). 2 Immunoassay UDS contain specific antibodies
Attachment E Annual ESTIMATED Usage based on 2007 volumes
Description Quantity # Orders Dept ABILIFY 10MG TABLET 660 22 Children's Vil. ABILIFY 15MG TABLET 150 4 Children's Vil. ABILIFY 20MG TABLET 300 10 Children's Vil. ABILIFY 5MG TABLET 840 20 Children's Vil.
MATERIAL SAFETY DATA SHEET (MSDS)/SAFETY DATA SHEET (SDS) General Chemistry 13
I. Product and Company Identification Product Name: Piccolo Reagent Disc A point of care blood diagnostic product Part Numbers: 400-1029 (single); 400-0029 (10 pack); 400-0029-4 (4 pack) Company Information:
Public Assessment Report Scientific discussion. Prednisolon Pilum (prednisolone) Asp no: 2013-0498
Public Assessment Report Scientific discussion Prednisolon Pilum (prednisolone) Asp no: 2013-0498 This module reflects the scientific discussion for the approval of Prednisolon Pilum. The procedure was
Public Assessment Report Scientific discussion. Amitriptylin Abcur (amitriptyline hydrochloride) Asp no : 2013-0678 2013-0679 2013-0680
Public Assessment Report Scientific discussion Amitriptylin Abcur (amitriptyline hydrochloride) Asp no : 2013-0678 2013-0679 2013-0680 This module reflects the scientific discussion for the approval of
PHARMACOTHERAPY UPDATE
PHARMACOTHERAPY UPDATE Benjamin Gross, Pharm D, BCPS, BCACP, BC ADM, CDE Associate Professor Director of Residency Programs Lipscomb University College of Pharmacy and Health Sciences 1 DISCLOSURE I DO
First Health Part D Value Plus (PDP) 2014 Formulary. (List of Covered Drugs)
2014 Formulary (List of Covered s) PLEASE READ: THIS DOCUMENT CONTAINS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN This formulary was updated on 10/28/2014. For more recent information or other questions,
Comprehensive PREFERRED DRUG LIST. Magnolia Health PDL
Comprehensive PREFERRED DRUG LIST Magnolia Health PDL GE 1 LAST UPDATED 12/2014 Pharmacy Program Magnolia Health Plan is committed to providing appropriate, high quality, and cost effective drug therapy
Attachment I Coverage of the Healthcare Products Sector
1 1211.10.10 - - Cut, crushed or powdered form 2 1211.10.90 - - Other 3 1211.20.10 - - Cut, crushed or powdered form 4 1211.20.90 - - Other 5 1211.30.10 - - Cut, crushed or powdered form 6 1211.30.90 -
Drugs with Anticholinergic Activity
PL Detail-Document #271206 This PL Detail-Document gives subscribers additional insight related to the Recommendations published in PHARMACIST S LETTER / PRESCRIBER S LETTER December 2011 Drugs with Anticholinergic
Clinically Significant Cardiovascular. Drug Interactions. April 30, 2014 Michael A Militello, PharmD, BCPS Cardiovascular Clinical Pharmacist
Clinically Significant Cardiovascular Drug Interactions April 30, 2014 Michael A Militello, PharmD, BCPS Cardiovascular Clinical Pharmacist Introduction Drug interactions represent 3-5% of preventable
Robert L. Talbert, Pharm. D. College of Pharmacy UT Austin. UT Health Science Center San Antonio
Therapeutic Substitution Robert L. Talbert, Pharm. D. College of Pharmacy UT Austin School of Medicine UT Health Science Center San Antonio Therapeutic Equivalence-Related Terms Approved Drug Products
Scanning Electron Microscopy Services for Pharmaceutical Manufacturers
Scanning Electron Microscopy Services for Pharmaceutical Manufacturers Author: Gary Brake, Marketing Manager Date: August 1, 2013 Analytical Testing Laboratory www.atl.semtechsolutions.com Scanning Electron
